Angelo Michael Ninivaggi, Jr. Sells 605 Shares of Plexus Corp. (NASDAQ:PLXS) Stock

Plexus Corp. (NASDAQ:PLXS) CAO Angelo Michael Ninivaggi, Jr. sold 605 shares of Plexus stock in a transaction on Monday, July 27th. The shares were sold at an average price of $73.00, for a total value of $44,165.00. Following the completion of the transaction, the chief accounting officer now owns 32,657 shares of the company’s stock, valued at $2,383,961. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

PLXS stock traded down $0.08 during mid-day trading on Thursday, hitting $73.97. 75,141 shares of the stock were exchanged, compared to its average volume of 229,280. The company has a debt-to-equity ratio of 0.24, a current ratio of 1.72 and a quick ratio of 0.93. The business has a fifty day moving average price of $68.01 and a 200 day moving average price of $65.20. Plexus Corp. has a 12 month low of $35.16 and a 12 month high of $86.53. The stock has a market capitalization of $2.16 billion, a price-to-earnings ratio of 19.02 and a beta of 1.05.

Plexus (NASDAQ:PLXS) last issued its quarterly earnings results on Wednesday, July 22nd. The technology company reported $1.20 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.75 by $0.45. Plexus had a return on equity of 12.41% and a net margin of 3.55%. The firm had revenue of $857.39 million during the quarter, compared to analyst estimates of $801.94 million. As a group, equities analysts forecast that Plexus Corp. will post 3.93 EPS for the current fiscal year.

Several research firms recently issued reports on PLXS. ValuEngine lowered Plexus from a “hold” rating to a “sell” rating in a research note on Thursday, July 23rd. Needham & Company LLC lifted their price objective on Plexus from $67.00 to $82.00 and gave the company a “buy” rating in a research note on Friday, July 24th. TheStreet raised Plexus from a “c+” rating to a “b” rating in a research note on Wednesday, July 22nd. Stifel Nicolaus lifted their price objective on Plexus from $60.00 to $80.00 and gave the company a “hold” rating in a research note on Friday, July 24th. Finally, Zacks Investment Research raised Plexus from a “hold” rating to a “buy” rating and set a $76.00 price objective for the company in a research note on Monday. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and six have given a buy rating to the company. Plexus currently has an average rating of “Buy” and an average price target of $80.67.

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Mason Street Advisors LLC increased its holdings in shares of Plexus by 2.2% in the fourth quarter. Mason Street Advisors LLC now owns 10,163 shares of the technology company’s stock worth $782,000 after buying an additional 221 shares during the period. State of Alaska Department of Revenue increased its holdings in shares of Plexus by 1.7% in the second quarter. State of Alaska Department of Revenue now owns 27,531 shares of the technology company’s stock worth $1,942,000 after buying an additional 470 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in shares of Plexus by 18.7% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,105 shares of the technology company’s stock worth $219,000 after buying an additional 489 shares during the period. Point72 Hong Kong Ltd purchased a new position in shares of Plexus in the fourth quarter worth about $39,000. Finally, JPMorgan Chase & Co. increased its holdings in shares of Plexus by 2.0% in the first quarter. JPMorgan Chase & Co. now owns 28,029 shares of the technology company’s stock worth $1,529,000 after buying an additional 552 shares during the period. Hedge funds and other institutional investors own 95.26% of the company’s stock.

Plexus Company Profile

Plexus Corp., together with its subsidiaries, provides electronic manufacturing services in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. It offers design and development, supply chain, new product introduction, and manufacturing solutions, as well as aftermarket services. The company provides its solutions to companies in the healthcare and life sciences, industrial and commercial, communications, and aerospace and defense sectors.

Featured Article: Why is momentum important to successful trading?

Insider Buying and Selling by Quarter for Plexus (NASDAQ:PLXS)

Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.